Royalty Pharma plc (RPRX) – Management Comments
-
BioCryst Pharma (BCRX) Adds $350 Million in New Financing with Royalty Pharma (RPRX) and OMERS Capital Markets
-
Dicerna Pharma (DRNA) Sells OXLUMO Royalty Interest to Royalty Pharma (RPRX) for Up to $240 Million
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RPRX Stock Lookup